Kay NE - Search Results

1

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE. Shanafelt TD, et al. Among authors: kay ne. Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x. Br J Haematol. 2008. PMID: 18275431 Free PMC article.

2

Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male.

Kay NE, Bone N, Hupke M, Dalmasso AP. Kay NE, et al. Blood. 1990 May 15;75(10):2024-9. Blood. 1990. PMID: 2140062 Free article.

3

Defective expression of T cell antigens in chronic lymphocytic leukaemia: relationship to T cell dysfunction.

Kay NE, Kaplan ME. Kay NE, et al. Br J Haematol. 1984 May;57(1):105-11. doi: 10.1111/j.1365-2141.1984.tb02870.x. Br J Haematol. 1984. PMID: 6609711

4

Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells.

Mu X, Kay NE, Gosland MP, Jennings CD. Mu X, et al. Among authors: kay ne. Br J Haematol. 1997 Mar;96(4):733-5. doi: 10.1046/j.1365-2141.1997.d01-2107.x. Br J Haematol. 1997. PMID: 9074413 Free article.

5

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.

Kay NE, Leong T, Bone N, Kyle RA, Greipp PR, Van Ness B, Oken MM. Kay NE, et al. Br J Haematol. 1998 Mar;100(3):459-63. doi: 10.1046/j.1365-2141.1998.00609.x. Br J Haematol. 1998. PMID: 9504626 Free article. Clinical Trial.

6

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

Kay N, Leong T, Kyle RA, Greipp P, Van Ness B, Bone N, Oken MM. Kay N, et al. Leuk Lymphoma. 1999 Mar;33(1-2):127-33. doi: 10.3109/10428199909093733. Leuk Lymphoma. 1999. PMID: 10194129 Clinical Trial.

7

Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients.

Fonseca R, Trendle MC, Leong T, Kyle RA, Oken MM, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Among authors: kay ne. Br J Haematol. 2000 Apr;109(1):24-9. doi: 10.1046/j.1365-2141.2000.01960.x. Br J Haematol. 2000. PMID: 10848778 Free article. Clinical Trial.

8

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.

Kay NE, Han L, Bone N, Williams G. Kay NE, et al. Br J Haematol. 2001 Mar;112(3):760-7. doi: 10.1046/j.1365-2141.2001.02605.x. Br J Haematol. 2001. PMID: 11260081 Free article.

9

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Jun;25(6):485-6. doi: 10.1016/s0145-2126(01)00008-x. Leuk Res. 2001. PMID: 11337021 No abstract available.

10

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Aug;25(8):709-10. doi: 10.1016/s0145-2126(01)00002-9. Leuk Res. 2001. PMID: 11397477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page